Decreased succinate dehydrogenase B in human hepatocellular carcinoma accelerates tumor malignancy by inducing the Warburg effect
Po‐Lin Tseng(Chang Gung University), Wen‐Tsan Chang(Kaohsiung Medical University), Chien‐Feng Li(Kaohsiung Municipal Ta-Tung Hospital), Chih‐Wei Chen(Chi Mei Medical Center), Wei-Hsuan Wu(National Cheng Kung University), Meng-Che Hsieh(National Cheng Kung University), Jiin-Haur Chuang(Chang Gung University), Wen-Hui Tsai(Chi Mei Medical Center), Tsung‐Hui Hu(National Sun Yat-sen University), Hung-Chi Cheng(National Cheng Kung University), Hui-Ju Tsai(National Cheng Kung University)
Cited by 100
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Hepatogastroenterology
|Hepatogastroenterology|2012|536
Pre-S Deletion and Complex Mutations of Hepatitis B Virus Related to Advanced Liver Disease in HBeAg-Negative Patients
|Gastroenterology|2007|232
Four‐year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|Liver International|2016|221
Clinical characteristics and prognostic factors of splenic abscess: A review of 67 cases in a single medical center of Taiwan
|World Journal of Gastroenterology|2006|217